Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Nanobiotix S.A. for the month of October 2025. The filing, dated October 15, 2025, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a standalone financial statement.
Material Changes
The filing text does not provide data to compare against prior periods. No material changes in financial metrics are detailed within the cover page text.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are contained within the attached press release (Exhibit 99.1), the text of which is not included in the provided input. The filing itself contains no specific commentary or risk disclosures.
Key Facts for Investor Verification
- Verify the content of the press release dated October 15, 2025, attached as Exhibit 99.1, as it contains the substantive information referenced by this filing.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that the Chief Financial Officer, Bart Van Rhijn, signed the report on behalf of the registrant.